Biaxol Ibutamoren MK-677, also known as Ibutamoren or MK-677, is an orally administered growth-hormone secretagogue that has been studied for its effects on growth-hormone and IGF-1 signaling.
This product should not be promoted as a general supplement for athletes, bodybuilders, children, or patients.
Do not use the product as a self-directed medicine or dietary supplement. Any handling or administration in a legitimate research or clinical setting should follow the applicable research protocol, local regulations and qualified professional guidance.
We do not recommend publishing a consumer dosage or cycle schedule for MK-677 because ibutamoren is not an FDA-approved medicine and its safety and efficacy for general consumer use have not been established.
Ibutamoren, commonly called MK-677, is an orally active growth-hormone secretagogue studied for its effects on growth-hormone and IGF-1 signaling.
No. Ibutamoren is generally classified as a growth-hormone secretagogue, not a selective androgen receptor modulator (SARM).
No. FDA states that ibutamoren is an active ingredient that is not approved by FDA, and its safety and efficacy have not been established.
Well Mart's current listing specifically describes it as a product intended for research purposes and states that it is not a dietary supplement or medicine.
Nutrobal is another name commonly associated with Ibutamoren/MK-677.
Research has examined growth-hormone and IGF-1 signaling, lean-mass-related outcomes, recovery, sleep indicators and appetite regulation.
It should not be marketed as an approved bodybuilding treatment or supplement. Any research involving MK-677 should be conducted within an appropriate professional and regulatory framework.
Ibutamoren has been studied as a growth-hormone secretagogue, meaning it stimulates growth-hormone release. However, this does not mean it is an approved treatment for increasing growth hormone in consumers.
Potential concerns reported by FDA include increased appetite, water retention, fatigue, muscle pain and possible changes in glucose metabolism and insulin sensitivity. Long-term effects remain unknown.
Self-directed use is not recommended. Discuss potential risks, interactions and suitability with a qualified healthcare professional.
This product should not be recommended for children. Ibutamoren is not FDA-approved, and its safety and efficacy have not been established.
Long-term safety has not been established. FDA specifically notes that the long-term effects of ibutamoren are unknown.
Unapproved products can have inaccurate labeling or undeclared ingredients. Regulators have documented cases of unapproved MK-677 products containing undeclared substances.
Well Mart currently lists Biaxol Ibutamoren MK-677 Capsules for Rs. 5,000 PKR, subject to availability and current store pricing.
No. The Well Mart listing states that it is intended for research purposes and is not a dietary supplement or medicine.
Customers Reviews For Biaxol Ibutamoren MK-677 Capsules in Pakistan